Tuesday, June 2, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Lived Experience is Data

Data is never data alone. It exists through an interpretation

Daily Remedy by Daily Remedy
April 19, 2023
in Contrarian
0
Lived Experience is Data

Creative Commons

Data is never data alone. It exists through an interpretation. The two are forever connected: data and its interpretation. We miss this when we’re arguing over the numbers, but what we interpret defines how we react to the data.

The opioid litigation settlements have garnered gargantuan amounts of funds for communities across the nation. But when spread out and averaged over time, the numbers thin out. Critical decisions about how to spend the money will determine how effective the settlement dollars prove to be. This requires, above all else, correctly interpreting the data.

We need the lived experiences of patients. Their interpretations make sense out of the data. Think of this way: numbers tell us about a specific event. But they never explain how multiple events relate. Those relationships come from lived experiences.

If we take two rural towns, both experiencing layoffs, and measure overdose rates, we’ll likely find similar metrics based on similar demographics. That only tells us the result of how the overdose crisis affected both towns. It doesn’t tell us how addictions are likely to form or what patterns of behavior are likely to lead someone down the path of addiction. Those are the lived experiences.

Lived experiences tell us the story. Data points tell us individual events. Those events are meaningless without the context of a narrative. In engineering parlance, we call this thinking in systems.

In systems, we focus on the interactions, the connections between events. That’s the actual story of addiction: a person’s relationship with his or her community. Each town has a different array of interactions that lead to distinct patterns of behavior. Within this complex framework, a patient with substance use dependency can turn into an addict. Just as well, an addict can turn into a patient with substance use dependency. There’s no data point that explains it all, because it can’t be explained through numbers.

We need stories. We need to hear from those most affected. Their stories aren’t just important to hear, they’re relevant for making critical decisions, such as deciding whether to invest in more freely available fentanyl strips or to offer more Narcan dispensaries. That decision, as nuanced as it may appear to be, will sway the scales toward fewer addictions. It may seem negligible. But that’s because you lack the lived experiences to see how impactful those subtleties can be.

Those who lived through the opioid crisis proudly carry their stories like scars of honor. Their lived experiences make them subject matter experts. In war, we heed the advice of soldiers because they lived through combat. Their experience becomes their expertise. That’s why we award medals for combat.

It’s time we give the same respect to those with lived experiences in the opioid crisis. Instead, we see these individuals written off as grief stricken or lacking the objective disposition necessary to inform policy decisions. That perspective misses the mark.

Nothing about addiction is objective. Even the clinical metrics we use to measure it are subjective. This is why we struggle to define, diagnose, and treat it. Addiction defies our innate tendency to objectify things in healthcare. Instead of acknowledging this, and looking at addiction through lived experiences, we look for something measurable, even if it’s a poor marker of addiction.

When it comes to money and metrics in the opioid epidemic, we need fewer numbers and more lived experiences. Remember, data is never data alone. It exists through an interpretation.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A man wearing a suit raising a judge's gavel beside a small model hospital building on a desk in a bright office.

    When Hospitals Can Be Liable for Abusive Providers

    0 shares
    Share 0 Tweet 0
  • Observations From the Rx & Illicit Drug Summit

    0 shares
    Share 0 Tweet 0
  • Case Analysis of Dr. Ball

    1 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Employers Don’t Really Care About Your Mental Health

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy